Teva- Pharmaceutical Industries Overview
Teva- Pharmaceutical Industries (TEVA) has a P/E ratio of 57.81, above the Healthcare sector average of 25.9.
Get informed when a big investor buys or sells
+ Follow57.81
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, TEVA shows a P/E ratio of 57.81. That is above the Healthcare sector average of 25.9. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 25.9. Teva- Pharmaceutical Industries is at 57.81, which is higher that average. That is roughly 123.2% above the sector mean. Use the comparison chart on this page to see how TEVA stacks up against individual peers as well.
Investors watch TEVA's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Teva- Pharmaceutical Industries's latest reading is 57.81. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Teva- Pharmaceutical Industries's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 57.81) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 25.9, while TEVA is at 57.81. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
